Spiro-indolines as y5 receptor antagonists

Details Spiro-indolines as y5 receptor antagonists Spiro-indolines as y5 receptor antagonists

C - Chemistry, Metallurgy

07

D

C07D 471/10 (2006.01) C07C 233/58 (2006.01) C07D 209/54 (2006.01) C07D 209/96 (2006.01) C07D 211/98 (2006.01) C07D 221/20 (2006.01) C07D 233/70 (2006.01) C07D 261/20 (2006.01) C07D 277/64 (2006.01) C07D 285/08 (2006.01) C07D 333/36 (2006.01) C07D 401/08 (2006.01) C07D 471/20 (2006.01)

Patent

CA 2350714

Compounds of general structural formula (I) such as that shown in structural formula (II) are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.

Composés de formule structurale générale (I) tels que ceux représentés par la formule (II), qui sont des antagonistes de récepteur NPY Y5, utiles pour traiter l'obésité et les complications associées.

Affiliated with

Also associated with

Rating

Spiro-indolines as y5 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro-indolines as y5 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-indolines as y5 receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1526326